Filter
929
Text search:
Antigen
testing
Featured
Recommendations
140
New Publications
225
Language
Document type
No document type
426
Guidelines
230
Studies & Reports
115
Manuals
61
Fact sheets
40
Strategic & Response Plan
30
Training Material
11
Situation Updates
4
Resource Platforms
4
Infographics
3
Online Courses
3
Videos
1
Countries / Regions
India
57
Global
40
South Africa
24
Nigeria
20
Kenya
19
Tanzania
18
Western and Central Europe
16
Africa
16
Uganda
14
Zambia
14
Philippines
13
East and Southern Africa
13
Sierra Leone
12
Germany
12
Nepal
11
Rwanda
11
Namibia
11
Ukraine
11
West and Central Africa
11
Liberia
10
Russia
10
Ghana
9
Malawi
9
Latin America and the Carribbean
9
Ethiopia
8
Zimbabwe
8
Bangladesh
6
Myanmar / Burma
6
Middle East and North Africa
6
Eastern Europe and Central Asia
6
Congo, Democratic Republic of
5
Syria
5
Cambodia
4
Mozambique
4
Brazil
4
Eastern Europe
4
USA
3
Saudi Arabia
3
Cameroon
3
Indonesia
3
Lesotho
3
South–East Asia Region
3
Albania
3
Burkina Faso
2
Somalia
2
Pakistan
2
Iraq
2
Jordan
2
Lebanon
2
Sudan
2
Eswatini/ Swaziland
2
Colombia
2
Libya
2
Asia
2
Iran
2
Guinea
1
Mali
1
Morocco
1
Haiti
1
South Sudan
1
Afghanistan
1
Egypt
1
China
1
Central African Republic
1
Peru
1
North Macedonia
1
Ecuador
1
Botswana
1
Greece
1
Angola
1
Madagascar
1
Sri Lanka
1
Chile
1
Yemen
1
Palestine
1
Djibouti
1
Qatar
1
Moldova
1
Kazakhstan
1
Georgia
1
North America
1
Tunisia
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
334
Clinical Guidelines
131
Pharmacy & Technologies
46
Public Health
26
Key Resources
20
Women & Child Health
19
Capacity Building
10
Toolboxes
COVID-19
170
HIV
136
NTDs
71
TB
64
Ebola & Marburg
36
Rapid Response
32
Malaria
22
2.0 Rapid Response
16
Refugee
15
Pharmacy
15
Zika
13
Conflict
10
Mental Health
10
AMR
10
Caregiver
10
Cholera
9
Polio
4
Health Financing Toolbox
4
Natural Hazards
3
Planetary Health
3
NCDs
3
Global Health Education
2
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi
...
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto
...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa
...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm
...
The COVID-19 pandemic has led to large increases in healthcare waste, straining under resourced healthcare facilities and exacerbating environmental impacts from solid waste. This report quantifies the additional COVID-19 healthcare waste generated, describes current healthcare waste management syst
...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors.
...
23 March 2021
The meeting addressed the last key area, that is, determining the best method or combination of diagnostic methods for a control programme for S. stercoralis infections in humans.
Dr Montresor’s presentation highlighted that while there is currently no “gold standard” for the
...
In this document, recommendations are provided on designing and implementing
a cross-sectional serosurvey using school-based sampling to estimate age-specific
DENV seroprevalence to inform a country’s national dengue vaccination program.
The document includes recommendations for methods for
...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im
...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a
...
The 2018 NDHS is a national sample survey that provides up-to-date information on demographic and health indicators. The sample was selected using a stratified, two-stage cluster design, with enumeration areas (EAs) as the sampling units for the first stage. The second stage was a complete listing o
...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im
...
The Interim Guidance on Cholera Rapid Diagnostic Tests (RDTs) by the Global Task Force on Cholera Control (GTFCC) provides recommendations for using RDTs to detect cholera in areas with limited laboratory capacity. It highlights the advantages of RDTs, such as rapid detection (within 30 minutes), ea
...
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot
...
The coronavirus outbreak that began in 2019 (COVID-19) threatens to reverse years of hard-won gains in preventing and treating HIV. Fragile health systems are further stressed as health workers navigate an increased client load and demands at work while also being concerned for their own health and
...
HAT diagnosis relies on laboratory techniques because clinical signs and symptoms are unspecific. Serodiagnostic tests exist only for Tbg and are based on the detection of specific antibodies, thus they are not confirmatory of infection. With the current low disease prevalence, the positive predicti
...
23 Dec 2020. The aim of this document is to provide an update on the knowledge surrounding the role of children in the transmission of SARS-CoV-2 and the role of schools in the COVID-19 pandemic, based on the experience in the EU from August–December, 2020. This document also addresses transmissio
...
WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever
recommended
The new WHO guidelines provide clinical management recommendations for four of the most widespread arboviruses affecting humans: dengue, chikungunya, Zika, and yellow fever.
An integrated approach is vital, as these four diseases often present with similar symptoms, especially in the early stages
...
